WE CONNECT BIOTECH
Diverse in all areas of the biotech industry, from research & development, commercialisation and financing to multipliers:
This is our association.
BOARD
Our Executive Board works for the association on a pro-bono basis. The team not only takes on the traditional tasks from treasurer to secretary – some board members also act as regional contacts in order to ensure networking in all regions of Austria.
PETER LLEWELLYN-DAVIES
Founder & CEO Accellerate Partners
1. CHAIRMAN OF THE EXECUTIVE BOARD
Peter Llewellyn-Davies is an experienced biotech executive with over 40 years of international expertise in company formation, IPOs, M&A, and financing. As Founder & CEO of Accellerate Partners, he supports management teams in scaling and implementing growth strategies. He serves as Non-Executive Director of Shield Therapeutics plc and co-founded invIOs, a company developing innovative cancer immunotherapies, including treatments for brain tumors (glioblastoma). Previously, he led the restructuring and successful sale of Apeiron Biologics to a U.S. pharmaceutical group. Peter has been recognized as a Fellow of the London Institute for Banking and Finance for his contributions to global finance.
THOMAS MOSER
CEO Myllia Biotechnology & CFO / COO bit.bio discovery
VICE PRESIDENT AND SECRETARY
Dr. Thomas Moser brings over 25 years of experience in venture financing, IP commercialization, venture capital, and innovative start-ups. He is the founder and CEO of Myllia Biotechnology and serves as CFO/COO of bit.bio discovery in Vienna. The company leverages an advanced CRISPR screening platform to identify novel therapeutic targets in partnership with leading pharmaceutical and biotech companies.
GUIDO GUALDONI
CEO Epitome Therapeutics FlexCo
VICE PRESIDENT
Dr. Dr. Guido Gualdoni is the founder and CEO of G.ST Antivirals GmbH, a biopharmaceutical company developing antiviral therapeutics. He has led the company from an academic spin-off to Phase 2 clinical trials and secured over €10 million in funding. With several years of experience in internal medicine and his habilitation in immunology, he combines scientific expertise with entrepreneurial experience.
REINHARD KANDERA
CFO Celex Oncology Innovations ltd.
BOARD MEMBER AND TREASURER
DDr. Reinhard Kandera has more than 25 years of experience in the finance and healthcare sectors. He is currently working as a biotechnology and clean-tech CFO and serves on the Supervisory Board of Proxygen GmbH. In the past, he has served, among other roles, as CFO of Hookipa Pharma Inc. (Nasdaq, New York), Valneva SE (Euronext, Paris), and Intercell AG (Vienna Stock Exchange).
GREGOR WICK
CEO ANGIOS FLEXCO
BOARD MEMBER AND REGIONAL REPRESENTATIVE WEST
Dr. Gregor Wick has over 20 years of experience at international consulting companies in Germany, the UK and Austria with a focus on strategic planning, innovation management and venture capital. He is the founder and CEO of Angios GmbH in Innsbruck, which develops vascular organoids and antibodies in partnership with big pharma, biotech and universities in Europe and North America.
SOPHIE ZETTL
CBO YGION Biomedical GmbH
BOARD MEMBER
Dr. Sophie Zettl brings over 20 years of international business development experience in the biopharmaceutical industry, with a proven track record of building company value through high-value licensing transactions, R&D collaborations, strategic alliances, and fundraising. She has held business development roles in the UK, the US, and Austria, including positions at MedImmune/AstraZeneca, Arsanis Biosciences GmbH, and CEBINA GmbH. Currently, she is Chief Business Officer at Vienna-based YGION Biomedical GmbH, a biotechnology company developing targeted immunotherapies for cancer.
HEAD OFFICE
CHRISTINE LLEWELLYN-DAVIES
HEAD OF OPERATIONS
Dipl.-Ing. Christine Llewellyn-Davies manages the BIOTECH AUSTRIA office and is the first point of contact for all matters relating to members and external parties. Among other things, she is responsible for member and sponsor acquisition, event organization, public relations, and the national and international networking of the association. She has extensive management experience, particularly in association and non-profit management.
office@biotechaustria.org // Tel.: +43 670 603 06 01
MARLIES LUFTENSTEINER
OFFICE & EVENT MANAGER
Marlies Luftensteiner supports the management of the BIOTECH AUSTRIA office in organizational and operational tasks. Her responsibilities include, among others, contributing to the planning and implementation of events as well as supporting members and partners. Through her experience in the event sector, she brings relevant expertise to the organizational processes of the office.
office@biotechaustria.org // Tel.: +43 670 558 33 85
Ordinary Members
a:head bio AG
Wien
Human Pharmaceuticals/Therapies, Platforms and Instruments
a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
ABF Pharmaceutical Services GmbH
Wien
Human Pharmaceuticals/Therapies, Analytics and Services, Contract Manufacturing, Other
ABF focuses on complex clinical trials and offers logistic services through our global network. We provide efficient solutions for the packaging, distribution, QP release, transport and (cold) storage of IMP and cell-based therapies. ABF also operatives a PBMC lab network.
Ablevia biotech GmbH
Wien
Human Pharmaceuticals/Therapies
Ablevia develops molecular decoys for the rapid and selective removal of harmful antibodies from the blood. These new injectable biotherapeutics are specifically designed to target drug-neutralizing anti-drug antibodies or antibodies that block the function of viral gene therapy vectors.
ABS Biotechnologies GmbH
Tulln an der Donau
Human Pharmaceuticals/Therapies, Platforms and Instruments, Analytics and Services, Diagnostics
Akribes Biomedical GmbH
Wien
Human Pharmaceuticals/Therapies, Diagnostics
In Western countries alone, 20 million patients suffer from chronic wounds. Current treatment options remain unsatisfactory. Akribes Biomedical has developed the first personalized therapy testing platform and has identified and patented active compounds with previously unknown potential for the…
Angios Flexco
Innsbruck
Human Pharmaceuticals/Therapies, Diagnostics
Specialist in vascularization, regenerative medicine, and wound healing Antibodies for the treatment of diabetic retinopathy Future focus: vascular organoids for drug testing
Annikki GmbH
Raaba-Grambach
Catalysts, Substrates, Precursors, Renewable Raw Materials
AOP Orphan Pharmaceuticals GmbH
Wien
Human Pharmaceuticals/Therapies, Other
The European AOP Health Group, headquartered in Vienna, has been a European pioneer in integrated therapies for patients with rare diseases and in intensive care medicine for more than 25 years.
APEIRON Biologics GmbH
Wien
Human Pharmaceuticals/Therapies
In 2017, APEIRON received EU marketing authorization for APN311 (Dinutuximab Beta, Qarziba®) for the treatment of pediatric neuroblastoma (out-licensed to EUSA Pharma Ltd.).
Archimedlife GmbH
Wien
Clinical Contract Research, Analytics and Services, Contract Manufacturing, Contract Research, Diagnostics, Other
Austrianni GmbH
Wien
Human Pharmaceuticals/Therapies
Austrianni GmbH is a development company focused on the therapy and prevention of tuberculosis and other infectious diseases of global importance.
bespark bio GmbH
Wien
Human Pharmaceuticals/Therapies, Contract Research
bespark*bio provides advanced process development services for novel biotherapeutics such as viral vectors, bionanoparticles, and biologics. We combine pre-developed process modules with machine learning approaches. The result? Shorter development timelines and improved process understanding.
Bio-LogX FlexCo
Wien
Bio-LogX (BLX) is a VC-backed biotech translation engine turning high-potential lab discoveries into real-world medicines. We in-license prototype biological molecules that already show in vivo proof of concept, then design, de-risk, and develop them into clinical candidates and run clinical…
Biocrates Life Sciences AG
Innsbruck
Human Pharmaceuticals/Therapies, Platforms and Instruments, Clinical Contract Research, Analytics and Services, Contract Research, Diagnostics
Biosynth GmbH
Wien
Human Pharmaceuticals/Therapies, Catalysts, Substrates, Precursors, Analytics and Services, Contract Manufacturing, Contract Research, Diagnostics
BIT BIO Discovery GmbH
Wien
Platforms and Instruments, Contract Research
bit.bio discovery is a joint venture between Myllia Biotechnology (Vienna) and bit.bio (Cambridge), founded in 2020 and based in Vienna, Austria. The company has developed a functional genomics screening platform using iPSC-derived cell models and CRISPR technologies to study genes at scale. It…
Cellectric Biosciences GmbH
Wien
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Platforms and Instruments, Diagnostics
Cellectric Biosciences GmbH is developing an electrodynamic sample preparation platform for the fully automated isolation of cells from complex samples. In its first application area, Cellectric enables a tenfold acceleration of sepsis diagnosis using existing methods.
Conscio Pharma Austria GmbH
Eisenstadt
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Analytics and Services, Contract Research
Conscio Pharma Austria GmbH is your reliable partner for high-quality pharmaceutical analytics – GMP-certified, independent, and committed to customer satisfaction. We stand for analytical excellence, regulatory compliance, and a high level of flexibility throughout your product’s lifecycle.
Cutanos GmbH
Wien
Platforms and Instruments
The Max Planck spin-off Cutanos develops antigen-specific vaccines and innovative therapies for autoimmune diseases. Cutanos is financially supported by an international consortium of investors, a Pfizer ESF Grant, as well as grants from AWS and FFG.
dawn-bio GmbH
Wien
At dawn-bio we are redefining what is possible in reproductive medicine. Using our proprietary stem cell–based platform technology, we decode the biological signals that embryos need to thrive in nature and bring them to the IVF lab. Nurturing bright beginnings for future generations.
Discovery Evolution FlexCo
Vienna
Our mission is to transform the process of antibody discovery to enable targeting protein receptors such as GPCRs. By moving discovery from the bench to the digital world, we set free from limitations of lab-intensive assays.
EB Research Institute
Salzburg
The EB Research Institute is a non-profit biotech company (a joint venture between DEBRA Austria and Salzburg University Hospital). It develops therapies for epidermolysis bullosa (EB). A biobank and a drug discovery portfolio support our research.
ELARIS
Wien
ELARIS is on a mission to help people live healthier, longer lives by fighting infectious diseases that threaten healthy aging. Our lead program is a highly differentiated vaccine against C. difficile — a severe diarrheal, hospital-acquired infection that hits elderly populations the hardest.
Epitome Therapeutics FlexCo
Wien
Epitome Therapeutics, a spin-off from EMBL Rome, is developing CADENCE, a dCas9-based epigenome editing platform that precisely activates or represses genes without altering DNA, with the aim of treating genetic diseases that currently have no cure.
EVOMEDIS GmbH
Graz
Human Pharmaceuticals/Therapies, Contract Research
EVOMEDIS specializes in the development of novel therapies for the treatment of burns and chronic wounds. EVOMEDIS aims to become the world’s leading R&D specialist in wound therapies. The company’s guiding paradigm is: wound healing rather than “just” wound management.
Exalt FLexCo
Wien
exalt® is a biotech spin-off, transforms patient care and develops a single-cell functional cancer test, fScreen, to select personalized treatments for cancer patients. The fScreen tests how a patient’s own tumor cells respond to different cancer therapies — at the single-cell level in real-time.
F2G Biotech GmbH
Wien
Human Pharmaceuticals/Therapies, Clinical Contract Research
F2G is a UK headquartered biopharmaceutical company with subsidiaries in the US and Austria focused on the discovery, development and commercialisation of novel therapies for life-threatening invasive fungal infections.
Fianostics GmbH
Wiener Neustadt
Clinical Contract Research, Analytics and Services, Contract Manufacturing, Contract Research, Diagnostics
Based on the FluoBolt™ platform, Fianostics develops and manufactures R&D assays for biomarkers and sets new standards in preventive diagnostics with its INOOlab system, providing low-threshold access through pharmacies. Certified according to ISO 13485, Fianostics also offers contract development…
Fragrami GmbH
Vienna
Fragrami is redefining how the world sources high-value bioactives sustainably
Graph Therapeutics
Klosterneuburg
Graph is a precision immunology techbio that leverages perturbation modeling from primary samples combined with multi-omics to deliver transformative targeted therapies and biomarkers for immune-driven diseases.
HeartBeat.bio AG
Wien
Human Pharmaceuticals/Therapies, Platforms and Instruments
HeartBeat.bio is dedicated to developing the first high-throughput human organoid screening platform for cardiac drug discovery. The technology platform is based on self-organizing, highly scalable cardiac organoids that recapitulate human heart physiology and enable the modeling of cardiac…
invIOs GmbH
Wien
Human Pharmaceuticals/Therapies
invIOs stands for Innovative Immuno-Oncology. We are pioneers in the research and development of drug candidates for cell therapies targeting novel immune checkpoints, as well as in the field of immunomodulation.
JLP Health GmbH
Wien
Human Pharmaceuticals/Therapies, Analytics and Services
JLP Health is a Vienna-based biotechnology company leveraging its innovative genetic screening platform to identify novel therapeutic targets and develop breakthrough treatment strategies for cancer and selected infectious diseases. The company’s lead program focuses on glioblastoma, one of the…
Kamosys Gmbh
Neutal
Human Pharmaceuticals/Therapies, Analytics and Services, Contract Manufacturing, IT and Services
We are an Office GMP Manufacturer supporting innovative biotech startups in becoming successful healthcare companies. We enable our customers to satisfy investors by accelerating market entry through our GMP QMS platform and our expertise in batch release as well as software-4-compliant document…
KinCon biolabs GmbH
Innbruck
Human Pharmaceuticals/Therapies, Platforms and Instruments, Analytics and Services, Contract Research
KinCon biolabs offers a genetically encoded reporter platform that monitors cellular interactions between drugs and proteins. Our technology provides insights into drug efficacy, specificity, and mechanism of action by observing drug-induced changes in the conformations of target proteins in living…
Lexogen GmbH
Wien
Platforms and Instruments, Analytics and Services, Diagnostics
Founded in 2007, Lexogen is a global leader in the fields of transcriptomics, next-generation sequencing, RNA analysis, and bioinformatics. Lexogen is the market leader in 3′ mRNA sequencing, a technology that has proven its efficiency and robustness.
LoopLab Bio GmbH
Wien
Human Pharmaceuticals/Therapies
Developing novel Fc engager-based immunotherapies for targeted induction of antigen-specific immune tolerance in autoimmune and inflammatory diseases.
Marinomed Biotech AG
Korneuburg
Human Pharmaceuticals/Therapies
Marinomed Biotech AG is an Austrian, publicly listed biotechnology company (VSE: MARI) with a growing development pipeline and globally marketed therapeutics. The company develops innovative, patent-protected products in the therapeutic areas of immunology and virology, based on its Marinosolv®…
Microsynth Austria GmbH
Wien
Analytics and Services, Contract Research
Microsynth (founded in 1989) is a leading European company specializing in nucleic acid synthesis and analysis. Its core activities are organized into three business areas: DNA/RNA Synthesis DNA/RNA Analysis and Sequencing Contract Research and Outsourcing Services
Miti Biosystems GmbH
Wien
Human Pharmaceuticals/Therapies
Miti Biosystems uses phage display technology of cyclic peptides, leveraging the ability of specialized enzymes found in nature to catalyze intramolecular amide bonds and thereby generate extremely stable, bioactive cyclic structures.
Mobius Biotechnology GmbH
Wien
Mobius is a discovery stage biotech utilising a unique, clinically validated platform to identify and develop novel anticancer drugs. Mice aren’t patients. Yet for decades, anticancer drug discovery has relied on animal models and cell lines that often fail to predict what actually happens in…
MouseTimer FlexCo
Viktring
IT and Services
We are a startup from Klagenfurt developing a project management solution for preclinical research. We optimize study coordination and work schedule creation with the help of our AI systems.
myBIOS GmbH
Graz
Contract Research
myBIOS provides solutions for the production of proteins and enzymes based on precision fermentation and the yeast Pichia pastoris. Building on its proprietary developments, myBIOS has established its own platform enabling methanol- and antibiotic-free production. We support our customers from…
MyeloPro Diagnostics and Research GmbH
Wien
Human Pharmaceuticals/Therapies, Contract Research, Diagnostics
Myllia Biotechnology GmbH
Wien
Platforms and Instruments, Contract Research
At Myllia, we perform pooled CRISPR screens in advanced cellular models such as primary human immune cells to map the impact of thousands of genetic perturbations at single-cell resolution – a new paradigm to nominate the best possible targets for your drug discovery campaign.
Nagene GmbH
Wien
Contract Manufacturing
Nagene develops and manufactures custom plasmid DNA and linear DNA fragments, with particular expertise in complex gene constructs. Its fully integrated production facility in Vienna enables fast turnaround times and operates under GMP-compliant conditions within an ISO 9001-certified quality…
NovoArc GmbH
Wien
Human Pharmaceuticals/Therapies, Platforms and Instruments, Analytics and Services, Contract Research
NovoArc uses a patented technology to replace injections with pills, enabling the oral delivery of medications by encapsulating them in special, highly stable lipids. This novel biological coating increases the shelf life of drugs, protects them in the stomach, and enhances their bioavailability.
OncoOne Research & Development GmbH
Klosterneuburg
Human Pharmaceuticals/Therapies
OncoOne is a biotechnology company specializing in the development of innovative antibody-based therapeutics for the treatment of cancer and autoimmune diseases.
Phoenestra GmbH
Linz
Human Pharmaceuticals/Therapies, Platforms and Instruments, Analytics and Services, Contract Manufacturing, Contract Research
Phoenestra develops technology platforms that enable novel human therapeutics. We pursue an end-to-end approach, from donor material through to GMP products. With EVscale™, we have developed a best-in-class technology for extracellular vesicles and (pre-)clinical products.
Polymun Scientific Immunbiologische Forschung GmbH
Klosterneuburg
Human Pharmaceuticals/Therapies
Polymun offers contract development and manufacturing services for biopharmaceuticals and liposomal/LNP formulations. Since 2001, Polymun has held a license for the manufacture of medicinal products in accordance with GMP guidelines. The company’s proprietary projects include biosimilars (FSH, Epo)…
print4biotech GmbH
Obersdorf
At print4biotech we are developing digital and 3D printed technologies for bioprocessing. With digital twins, automated design tools and 3D-printed bioreactor technologies we facilitate process scale up and optimization from bench to production scale.
Proxygen GmbH
Wien
Human Pharmaceuticals/Therapies
Proxygen is a biotech company developing therapies for cancer and other life-threatening diseases. By reprogramming the cellular recycling machinery, we can selectively degrade disease-relevant proteins. This enables us to address conditions that were previously considered untreatable.
QBDC GmbH
Neutal
QBDC GmbH is a deep tech company developing biological intelligence technologies for modern biopharmaceutical manufacturing. The company focuses on decoding the regulatory state of living cells to make bioprocess development faster, more predictable, and more efficient. Traditional process…
QUANTRO Therapeutics GmbH
Wien
Other
QUANTRO develops therapies for cancer and other diseases. Using time-resolved transcriptomic profiling, we discover novel therapeutic target proteins and their functional regulation: discovery of drugs controlling gene transcription factors with time-resolved transcriptomics.
QUBICON AG
Wien
Platforms and Instruments, Analytics and Services, IT and Services
Qubicon software stands for “Quality by Control” and supports users in the development and optimized operation of bioprocesses. Built on centralized process data management, Qubicon enables a wide range of advanced process monitoring and control capabilities.
RIANA Therapeutics GmbH
Wien
Human Pharmaceuticals/Therapies
RIANA Therapeutics develops novel drugs targeting challenging protein-protein interactions to treat cancer, utilizing its proprietary phenotypic drug discovery platform.
Ribbon Bio GmbH
Wien
Ribbon Biolabs is a leading company in the field of synthetic biology, advancing DNA synthesis beyond the limits of current technologies. With our automated, enzyme-based InfiniSynth™ platform, we can provide DNA molecules without size or sequence limitations, with high accuracy and unprecedented…
Sola Diagnostics GmbH
Innsbruck
Platforms and Instruments, Analytics and Services, Diagnostics
Sola Diagnostics focuses on cancer prevention through epigenetics-based risk prediction, benefiting both patients and society.
Solgate GmbH
Klosterneuburg
Human Pharmaceuticals/Therapies, Other
Solgate GmbH develops drugs targeting the family of “Solute Carrier” (SLC) proteins. Solgate offers its customers both the developed active compounds and various platform-based methods that enable the targeted identification of disease-relevant SLCs.
THT Biomaterials GmbH
Wien
Human Pharmaceuticals/Therapies, Renewable Raw Materials, Platforms and Instruments, Contract Manufacturing, Contract Research, Diagnostics
THT Biomaterials is replacing animal materials with sustainable and cheap human biomaterials from placenta, to de-risk and accelerate many medical translation processes (human-relevant; precision medicine; personalized medicine).
Tridem Bioscience FlexCo
Wien
Tridem Bioscience is a privately held biotech company based in Vienna, Austria. We are focusing on the discovery and development of innovative active immunotherapies based on our proprietary WISIT (WIn the Skin Immune system Trick) technology. We aim to realize this novel vaccine concept using…
VALIDOGEN GmbH
Raaba-Grambach
Platforms and Instruments, Contract Research
VALIDOGEN, a leading research and development company for protein production using the yeast Pichia pastoris, offers high-performance technologies for microbial strain and bioprocess development through its UNLOCK PICHIA® platform, enabling the competitive production of recombinant proteins.
Valneva Austria GmbH
Wien
Human Pharmaceuticals/Therapies
Valneva is a vaccine company specialized in the development, manufacturing, and commercialization of prophylactic vaccines against infectious diseases with significant unmet medical needs.
VelaLabs GmbH
Wien
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Clinical Contract Research, Analytics and Services
VelaLabs GmbH is a GMP / GLP-certified and G(C)LP-compliant contract laboratory. We offer Analytical services for Biologics (NBE, Biosimilars, vaccines, ATPMs), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release.
ViruSure GmbH
Wien
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Analytics and Services, Contract Manufacturing, Contract Research
ViruSure is an Austrian company and part of Asahi Kasei Bioprocess, specializing in virus and prion safety testing for biopharmaceutical products. We are a global leader in contract testing services for virus and prion safety, with a strong commitment to scientific excellence, customer service, and…
ViVerita Discovery FlexCo
Wien
Human Pharmaceuticals/Therapies, Contract Research
ViVerita Discovery is a next-generation precision oncology company. Built on its industry-leading in vivo discovery platform, the company is uniquely positioned to identify physiologically relevant novel targets and develop the next generation of precision therapies for the treatment of a wide…
Individual Members
Dr. Marc
Brehme
Dr. Marc Brehme
Landegg
Dr. Brehme combines his many years of international experience in Europe and the USA with valuable industry expertise in biotech and life sciences R&D, along with management, leadership, and entrepreneurship skills. He has been active and well-connected in Vienna’s biotech sector since 2005.
Helmut
Brunar
Helmut Brunar
Wien
Human Pharmaceuticals/Therapies
Dr. Helmut Brunar is an experienced life sciences expert and business consultant with a focus on pharma and biotech. He manages extensive CAPEX investment programs from planning to commissioning of new production sites for vaccines and cell & gene therapies, and also provides advisory services in…
Johannes
Grillari
Johannes Grillari
Wien
Johannes Grillari is Director of the Ludwig Boltzmann Institute for Traumatology, the Research Center in Cooperation with AUVA, and Professor at the Institute of Molecular Biotechnology at BOKU Vienna. From 2012 to 2019, he served as Scientific Director of the Christian Doppler Laboratory for Biotec
Karl
Petrovsky
Peter
Llewellyn-Davies
Peter Llewellyn-Davies
Altmünster am Traunsee
Peter Llewellyn-Davies is an experienced biotech executive with over 40 years of international expertise in company formation, IPOs, M&A, and financing. As Founder & CEO of Accellerate Partners, he supports management teams in scaling and implementing growth strategies. He serves as Non-Executive…
Thomas
Fischer
Supporting Members
AVIA GmbH
Schäftlarn
AVIA GmbH was founded in Hamburg in 1995 and has specialized in the insurance of special risks since 2011. Our primary focus is on the fields of biotechnology, biopharmaceuticals, CMOs, CROs, medical technology, and nanotechnology. In addition, we advise companies on all matters relating to…
Herbst Kinsky Rechtsanwälte GmbH
Wien
Other
Herbst Kinsky is one of the leading law firms in Austria. Since 2005, we have been providing legal advice in all areas of business and corporate law. Driven by curiosity, our team is always seeking new perspectives to stay one step ahead.
JOANNEUM RESEARCH Forschungsgesellschaft mbH
Graz
Clinical Contract Research, Analytics and Services, Contract Research, IT and Services, Other
We support clinical and preclinical activities in the fields of dermatology, metabolic research, and neurology through research services in the following areas: tissue-specific PK/PD studies, pharmaceutical analyses, bioanalyses, metabolomics, data management, and statistical analyses.
knowbio GmbH
Berlin
Other
Knowbio is an independent media and communications company dedicated to the European life sciences ecosystem. Based in Berlin, we report on innovations in biotechnology, pharmaceuticals, the bioeconomy, and medical technology, supporting these sectors through trusted journalism, intelligent…
KPMG Alpen-Treuhand GmbH
Wien
Other
KPMG stands for expertise in Advisory, Audit, Law & Tax and is active in Austria with around 2,000 employees at nine locations. Our specialists have extensive project experience and support companies, among other things, in the implementation of AI technologies or in KIS & SAP transformation in the…
Maiwald GmbH
München
Other
One of the largest and most renowned law firms in the field of intellectual property in Germany and Europe, with around 270 employees. We provide advice across all technologies and industries for a wide range of companies (start-ups, SMEs, multinational corporations) in Germany, Austria, and…
MC Services AG
München
Other
MC Services provides high-quality consulting to companies in the life sciences sector with its international team of experts in science, finance, media, and communications. The services include corporate and product communications, market access, investor relations, and financial transactions.
Talentor Austria GmbH
Wien
Other
Talentor Austria is part of an internationally leading executive search network headquartered in Austria. We specialize in the search and selection of executives and professionals in the life sciences and healthcare sectors. We find the \"Leaders for tomorrow\"!
Thermo Fisher Scientific
Wien
Platforms and Instruments, Clinical Contract Research, Analytics and Services, Contract Manufacturing, Contract Research
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical…
Associate Members
acib GmbH
Graz
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Catalysts, Substrates, Precursors, Grain/Food/Feed, Platforms and Instruments, Analytics and Services, Contract Manufacturing, Diagnostics, Other
The Austrian Centre of Industrial Biotechnology (acib) is a private, non-profit research institution with 30+ years of experience. In addition to its approx. 200 employees, it has framework contracts with several scientific partners in Austria and acts as a hub for industrial biotechnology in Europe
AIT Austrian Institute of Technology Gmbh / Center for Health & Bioresources
Wien
Human Pharmaceuticals/Therapies, Veterinary Pharmaceuticals/Therapies, Platforms and Instruments, Clinical Contract Research, Analytics and Services, Contract Research, IT and Services, Diagnostics
The AIT Austrian Institute of Technology is Austria\\\'s largest research and technology organisation with more than 1,600 employees working on the key infrastructure issues of the future. AIT focuses on the two interlinked research priorities of \"sustainable and resilient infrastructures\",…
ARGE LISAvienna
Wien
Other
LISAvienna is the cluster platform for life sciences in Vienna, established at the intersection of Austria Wirtschaftsservice and Vienna Business Agency. On behalf of the Federal Ministry for Labour and Economy and the City of Vienna, it contributes to the further development of the industry.…
CeMM
Wien
The mission of CeMM is to achieve the highest level of scientific innovation in molecular medicine in order to improve healthcare.
Health Hub Tirol GmbH
Innsbruck
Other
The objective of Health Hub Tirol, an initiative of the State of Tyrol, is to promote innovation in the fields of life sciences, medical technology, e-health, pharmaceuticals and biotechnology and to further enhance Tyrol’s profile as an internationally recognised healthcare industry location…
Hochschule Campus Wien, University of Applied Sciences
Wien
The University of Applied Sciences Campus Vienna offers hands-on, research-driven education. Its Molecular Biotechnology section focuses on health and biotech innovation, with the Molecular Biotechnology program combining lab skills, bioinformatics with a biopharma focus.
Human.technology Styria GmbH
Graz
Human.technology styria is a politico-economic initiative which sets out to boost the competitiveness of Styrian companies, institutions and scientific bodies working in the field of human technology. The cooperation in economics, research and research promotion will provide a guarantor for the…
MCI - Die Unternehmerische Hochschule
Innsbruck
Renewable Raw Materials, Clinical Contract Research, Other
MCI, as an Entrepreneurial University®, combines science, business, and consulting into a unique concept. It stands for internationality, academic excellence, practical relevance, innovation, close collaboration with industry, and solution-oriented research and development.
Medizinische Universität Wien
Wien
Medical University of Vienna (MedUni Vienna) is one of Europe\'s leading research establishments in the biomedical sector. The university is a renowned centre for translational medicine, uniting internationally recognized experts with deep expertise across the entire continuum of clinical…
Standortagentur Tirol GmbH
Innsbruck
With a comprehensive range of services, Standortagentur Tirol supports companies, research institutions, municipalities, and regions in their growth, digitalization, and start-up projects, helping them to connect regionally, nationally, and internationally. Through targeted consulting, networking,…
Universität für Bodenkultur (BOKU)
Wien
Human Pharmaceuticals/Therapies, Catalysts, Substrates, Precursors, Grain/Food/Feed, Renewable Raw Materials, Platforms and Instruments, Analytics and Services, Contract Research, Diagnostics
BOKU University is one of the best Life Sciences universities in Europe, distinguished by its holistic approach to research and teaching. Our scientists, students and graduates work on solutions for burning social issues and for a sustainable future. Today\'s BOKU University began its success…
Vienna BioCenter-Wissenschaftliche Standortgemeinschaft
Wien
Other
The Vienna BioCenter is a leading life sciences hub in Europe, offering a unique combination of research, education, and business on a shared campus: 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies.
WU WIEN / WU Executive Academy
Vienna
The WU Executive Academy, part of WU Vienna, offers outstanding executive education—from Executive MBA and Master of Laws programs to specialized Master programs. It stands out through its international faculty, triple accreditation, and a global network of professionals.
xista innovation GmbH
Klosterneuburg
Our team is composed of interdisciplinary individuals who are driven by their passion and curiosity for science and technology. We provide individual coaching and mentoring, as well as business development support and technical expertise. Our team\'s expertise in areas such as technology, finance,…
